James Tam

James Tam is a Principal Scientist at Nurix Therapeutics, where they focus on small molecules analytical development. With a broad background in analytical chemistry, James has held various roles including Senior Scientist at multiple organizations such as Gilead Sciences, MyoKardia, and Novartis, contributing to drug development through method validation and regulatory submissions. They began their career as a Chemist at Syntex and have since developed expertise in stability studies, method transfers, and analytical method development across various pharmaceutical settings. James earned a Bachelor of Arts in Chemistry from the University of California, Berkeley.